AZN AstraZeneca PLC ADR

$85.49

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/6/2025

About AstraZeneca PLC ADR

AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections, neuroscience and gastroenterology worldwide. The company is headquartered in Cambridge, the United Kingdom.

Website: https://www.astrazeneca.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
901832
Address
1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, GB
Valuation
Market Cap
$209.55B
P/E Ratio
30.04
PEG Ratio
0.96
Price to Book
6.19
Performance
EPS
$2.25
Dividend Yield
2.29%
Profit Margin
13.00%
ROE
17.60%
Technicals
50D MA
$73.24
200D MA
$73.97
52W High
$86.46
52W Low
$61.24
Fundamentals
Shares Outstanding
3B
Target Price
$84.79
Beta
0.25

AZN EPS Estimates vs Actual

● Estimated
● Actual

AZN News & Sentiment

Oct 06, 2025 • Benzinga NEUTRAL
Amgen To Offer Cholesterol Drug At 60% Discount - Amgen ( NASDAQ:AMGN )
Amgen Inc. ( NASDAQ:AMGN ) on Monday launched AmgenNow, a new direct-to-patient program starting with Repatha ( evolucumab ) . AMGN stock is trending lower. View the charts here.
Oct 06, 2025 • Benzinga SOMEWHAT-BULLISH
AstraZeneca Taps Gene Editing And AI Platform For Drug Discovery For Immunology Diseases - AstraZeneca ( NASDAQ:AZN )
Algen Biotechnologies, a privately held biotech company specializing in advanced CRISPR gene modulation and AI-driven drug discovery, has announced a multi-target partnership with AstraZeneca Plc ( NASDAQ:AZN ) to accelerate the discovery of novel therapeutic targets in immunology.
Oct 06, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Eli Lilly Stock Rises 16% in a Week: Here's What You Should Know
LLY shares have jumped 16% last week as Pfizer's landmark government deal boosted investor confidence across the pharma sector.
Oct 06, 2025 • Zacks Commentary SOMEWHAT-BULLISH
AbbVie Stock on the Move: What Sparked the 6% Jump in the Past Week?
ABBV shares rose 6% last week as optimism swept the pharma sector after Pfizer's landmark drug-pricing deal with the Trump administration.
Oct 06, 2025 • Benzinga NEUTRAL
AstraZeneca/Daiichi Sankyo Partnered Breast Cancer Drug Shows Survival Benefit Over Chemotherapy - AstraZeneca ( NASDAQ:AZN )
AstraZeneca Plc ( NASDAQ:AZN ) and Daiichi Sankyo on Monday released high-level results from the TROPION-Breast02 Phase 3 trial.
Oct 06, 2025 • Zacks Commentary SOMEWHAT-BULLISH
How J&J's Innovative Medicines Segment is Poised Ahead of Q3 Results
JNJ's Innovative Medicine sales face biosimilar pressure and IRA headwinds, but growth drivers like Darzalex, Tremfya and Erleada may have ensured steady Q3 momentum.
Sentiment Snapshot

Average Sentiment Score:

0.227
50 articles with scored sentiment

Overall Sentiment:

Bullish

AZN Reported Earnings

Apr 23, 2025
Mar 31, 2025 (Pre market)
-0.18 Surprise
  • Reported EPS: $0.93
  • Estimate: $1.12
  • Whisper: —
  • Surprise %: -16.3%
Feb 06, 2025
Dec 31, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $1.04
  • Estimate: $1.04
  • Whisper: —
  • Surprise %: 0.8%
Nov 12, 2024
Sep 30, 2024 (Pre market)
-0.58 Surprise
  • Reported EPS: $0.46
  • Estimate: $1.04
  • Whisper: —
  • Surprise %: -56.0%
Jul 25, 2024
Jun 30, 2024 (Pre market)
-0.21 Surprise
  • Reported EPS: $0.99
  • Estimate: $1.20
  • Whisper: —
  • Surprise %: -17.5%
Apr 25, 2024
Mar 31, 2024 (Pre market)
-0.19 Surprise
  • Reported EPS: $1.03
  • Estimate: $1.22
  • Whisper: —
  • Surprise %: -15.6%
Feb 08, 2024
Dec 31, 2023 (Pre market)
-0.06 Surprise
  • Reported EPS: $0.73
  • Estimate: $0.79
  • Whisper: —
  • Surprise %: -7.6%
Nov 09, 2023
Sep 30, 2023 (Pre market)
0.02 Surprise
  • Reported EPS: $0.87
  • Estimate: $0.85
  • Whisper: —
  • Surprise %: 2.4%
Jul 28, 2023
Jun 30, 2023 (Pre market)
0.13 Surprise
  • Reported EPS: $1.08
  • Estimate: $0.95
  • Whisper: —
  • Surprise %: 13.7%
Apr 27, 2023
Mar 31, 2023 (Pre market)
-0.11 Surprise
  • Reported EPS: $0.96
  • Estimate: $1.07
  • Whisper: —
  • Surprise %: -10.3%

Financials